Management Team

Martin Verhoef, President and CEO
Martin Verhoef, President and CEO, has 25 years experience in the life sciences research products and molecular diagnostics industry. He joined Mira Dx® in December 2010 from his prior position as President and CEO of PrimeraDx, an emerging Molecular Diagnostics company. In his three years at PrimeraDx Mr. Verhoef successfully developed and built a novel platform for quantitative multiplexed analysis of nucleic acids, put in place an experienced team and raised significant funds. Prior to PrimeraDx he was President of Ciphergen Biosystems, now known as Vermillion. Mr. Verhoef has also held various management positions at Hewlett-Packard/Agilent in their Life Sciences and Genomics programs. Mr. Verhoef holds a BS degree in Chemistry from the van ‘t Hoff Institute in Rotterdam, The Netherlands.

Bridget McDonough, Sales and Marketing Manager
Bridget McDonough, Sales and Marketing Manager, is a veteran of the pharmaceutical and molecular diagnostic space with a distinguished track record of sales growth achievements.  She joined Mira Dx® in May 2010.  Prior to Mira Dx®, Ms. McDonough had a career in sales with Myriad Genetics where she grew revenues significantly.  Ms. McDonough has also held various sales and marketing positions at Ortho-McNeil Pharmaceuticals, Biovail Pharmaceuticals, and Ther-Rx Corporation.  Miss McDonough holds a Bachelors Degree from Clemson University.